This page is specifically intended to support patients who have been prescribed Tafinlar + Mekinist by a UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.
Tafinlar + Mekinist patient resources: for metastatic melanoma patients
A guide to Tafinlar and Mekinist treatment for metastatic melanoma patients
Tafinlar + Mekinist patient resources: for adjuvant melanoma patients
A guide to Tafinlar and Mekinist treatment for adjuvant melanoma patients
HCP20-C042 September 2020.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.